Adherence is a huge problem, for patients, pharmaceutical companies, and the healthcare system as a whole. According to a study released by Capgemini Consulting and HealthPrize, the average lost revenue for all pharma drugs due to non-adherence is a staggering 59%, in other words, billions of dollars in potential revenue. Worse yet, patients who do [...]
The “patent cliff” is here, with patents on blockbuster drugs such as Singulair, Plavix, Seroquel and Actos expiring, and it is critical that pharmaceutical companies listen to what patients are saying about generic alternatives. Preconceptions and opinions about generic medications abound, but do patients have their facts straight? Analyzing thousands of patient discussions on health [...]
